Table 2 Details of symptoms lasted longer than four weeks in the participants
From: Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients
| Â | Number | Duration (days) |
|---|---|---|
Fatigue | 58 (12.7) | 50 [30–60] |
Hair loss | 55 (12.0) | 60 [30–90] |
Cough | 54 (11.8) | 40 [30–60] |
Dysosmia | 47 (10.3) | 45 [30–60] |
Dysgeusia | 47 (10.3) | 35 [30–60] |
Shortness of breath | 36 (7.9) | 42.5 [30–60] |
Loss of concentration | 34 (7.4) | 40 [30–90] |
Depression | 29 (6.3) | 40 [30–60] |
Chest pain | 18 (3.9) | 60 [40–98] |
Appetite loss | 17 (3.7) | 30 [30–60] |
Headache | 17 (3.7) | 44 [30–60] |
Memory disturbance | 15 (3.3) | 60 [30–90] |
Sputum | 14 (3.1) | 43 [30–60] |
Fever | 11 (2.4) | 30 [30–45] |
Joint pain | 8 (1.8) | 48 [30–98] |
Myalgia | 5 (1.1) | 40 [30–60] |
Sore throat | 5 (1.1) | 30 [30–50] |
Runny nose | 5 (1.1) | 30 [30–31] |
Red-eye | 4 (0.9) | 60 [58–75] |
Diarrhoea | 2 (0.4) | 33 [31–34] |
Nausea | 1 (0.2) | 30 [30–30] |
Abdominal pain | 0 (0.0) | NA |